Basics Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $651.06B Activated in VL: True Average Daily Range Avg Daily Range: $1.65 | 0.94% Avg Daily Range (30 D): $13.98 | 1.78% Avg Daily Range (90 D): $13.74 | 1.71% Institutional Daily Volume Avg Daily Volume: 4.37M Avg Daily Volume (30 D): 4.03M Avg Daily Volume (90 D): 3.27M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 28 Avg Trade Size (Sh.) (90 D): 28 Institutional Trades Total Inst.Trades: 85,433 Avg Inst. Trade: $8.73M Avg Inst. Trade (30 D): $72.72M Avg Inst. Trade (90 D): $76.7M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 15 Market Closing Trades Avg Closing Trade: $80.48M Avg Closing Trade (30 D): $356.1M Avg Closing Trade (90 D): $388.33M Avg Closing Volume: 421.4K         News Jun 2, 2025 @ 4:07 PM Healthcare Sector Setting Up for a Catch-Up Trade ... Source: Brian Gilmartin Jun 1, 2025 @ 11:30 PM Nxera Pharma Achieves Development Milestone in Col... Source: N/A May 30, 2025 @ 8:21 AM Looking for a Blend of Growth and Dividend Stocks ... Source: The Motley Fool May 29, 2025 @ 9:42 AM Drug Device Combination Products Market Analysis R... Source: Na May 28, 2025 @ 8:15 AM Novo Nordisk's 52% Plunge: Is the Company Fumbling... Source: The Motley Fool Financials   TTM Q1 2025 Q4 2024 Basic EPS $12.34 $3.07 $4.9 Diluted EPS $12.29 $3.06 $4.88 Revenue $ 49B $ 12.73B $ 13.53B Gross Profit $ 40.03B $ 10.5B $ 11.13B Net Income / Loss $ 11.11B $ 2.76B $ 4.41B Operating Income / Loss $ 13.6B $ 3.46B $ 5.04B Cost of Revenue $ 8.97B $ 2.22B $ 2.4B Net Cash Flow $ 633.1M $ -175.1M $ -100.6M PE Ratio 60.22